Disruption of the putative splice acceptor site for SIVmac239 Vif reveals tight control of SIV splicing and impaired replication in Vif non-permissive cells

Virology

Volumn 338, Issue 2, 2005, Pages 281-291

  Victoria, Joseph G ^a   Robinson Jr , W Edward ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; APOBEC3G; Cytosine deamination; DNA hypermutation; mRNA; Real time polymerase chain reaction

Indexed keywords

MESSENGER RNA; VIF PROTEIN;

ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; MUTATION; PRIORITY JOURNAL; RNA EDITING; RNA SPLICING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CONSENSUS SEQUENCE; DNA REPLICATION; GENE PRODUCTS, VIF; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; RNA, VIRAL; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC;

SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 22544459905     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.05.007     Document Type: Article

References (67)

1. B.A. Amendt, D. Hesslein, L.J. Chang, and C.M. Stoltzfus Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1 Mol. Cell. Biol. 14 1994 3960 3970
2. P.S. Bilodeau, J.K. Domsic, A. Mayeda, A.R. Krainer, and C.M. Stoltzfus RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element J. Virol. 75 2001 8487 8497
3. H.P. Bogerd, B.P. Doehle, H.L. Wiegand, and B.R. Cullen A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor Proc. Natl. Acad. Sci. U. S. A. 101 2004 3770 3774
4. A.M. Borman, C. Quillent, P. Charneau, C. Dauguet, and F. Clavel Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity J. Virol. 69 1995 2058 2067
5. M. Caputi, and A.M. Zahler SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D EMBO J. 21 2002 845 855
6. L. Cartegni, S.L. Chew, and A.R. Krainer Listening to silence and understanding nonsense: exonic mutations that affect splicing Nat. Rev. Genet. 3 2002 285 298
7. S.G. Conticello, R.S. Harris, and M.S. Neuberger The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G Curr. Biol. 13 2003 2009 2013
8. R.C. Desrosiers, J.D. Lifson, J.S. Gibbs, S.C. Czajak, A.Y. Howe, L.O. Arthur, and R.P. Johnson Identification of highly attenuated mutants of simian immunodeficiency virus J. Virol. 72 1998 1431 1437
9. J.K. Domsic, Y. Wang, A. Mayeda, A.R. Krainer, and C.M. Stoltzfus Human immunodeficiency virus type 1 hnRNP A/B-dependent exonic splicing silencer ESSV antagonizes binding of U2AF65 to viral polypyrimidine tracts Mol. Cell. Biol. 23 2003 8672 8762
10. M.R. Furtado, R. Balachandran, G. Phalguni, and S.M. Wolinksy Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein Virology 185 1991 258 270
11. D.H. Gabuzda, K. Lawerence, E. Langhoff, E. Terwilliger, T. Dorfman, W.A. Haseltine, and J. Sodroski Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes J. Virol. 66 1992 6489 6495
12. N.C. Gaddis, E. Chertova, A.M. Sheehy, L.E. Henderson, and M.H. Malim Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions J. Virol. 77 2003 5810 5820
13. N.C. Gaddis, A.M. Sheehy, K.M. Ahmad, C.M. Swanson, K.N. Bishop, B.E. Beer, P.A. Marx, F. Gao, F. Bibollet-Ruche, B.H. Hahn, and M.H. Malim Further investigation of simian immunodeficiency virus Vif function in human cells J. Virol. 78 2004 12041 12046
14. M.A. Garcia-Blanco Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing J. Clin. Invest. 112 2003 474 480
15. E.D. Garrett, L.S. Tiley, and B.R. Cullen Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products J. Virol. 65 1991 1653 1657
16. J.S. Gibbs, D.A. Regier, and R.C. Desrosiers Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes AIDS Res. Hum. Retroviruses 10 1994 333 342
17. J. Goncalves, Y. Korin, J. Zack, and D. Gabuzda Role of Vif in human immunodeficiency virus type 1 reverse transcription J. Virol. 70 1996 8701 8709
18. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 133 2003 803 809
19. G.C. Jayan, and J.L. Casey Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2 J. Virol. 76 2002 3819 3827
20. S. Kao, M.A. Khan, E. Miyagi, R. Plishka, A. Buckler-White, and K. Strebel The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity J. Virol. 77 2003 11398 11407
21. D.E. Kellogg, and S. Kwok Detection of human immunodeficiency virus M.A. Innis D.H. Gelfand J.J. Sninsky PCR Protocols: A Guide to Methods and Applications 1990 Academic Press, Inc. San Diego 337 347
22. P.J. King, and W.E. Robinson Jr. Resistance to the anti-human immunodeficiency virus type 1 compound l-chicoric acid results from a single mutation at amino acid 140 of integrase J. Virol. 72 1998 8420 8424
23. M. Kobayashi, A. Takaori-Kondo, K. Shindo, A. Abudu, K. Fukunaga, and T. Uchiyama APOBEC3G targets specific virus species J. Virol. 78 2004 8238 8244
24. J. Krummheuer, C. Lenz, S. Kammler, A. Scheid, and H. Schaal Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression Virology 286 2001 276 289
25. J.A. Lake, J. Carr, F. Feng, L. Mundy, C. Burrell, and P. Li The role of Vif during HIV-1 infection: interaction with novel host cellular factors J. Clin. Virol. 26 2003 143 152
26. K. Luo, B. Liu, Z. Xiao, Y. Yu, X. Yu, R. Gorelick, and X.F. Yu Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging J. Virol. 78 2004 11841 11852
27. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
28. B. Mangeat, P. Turelli, S. Liao, and D. Trono A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action J. Biol. Chem. 279 2004 14481 14483
29. A. Manns, H. Konig, M. Baier, R. Kurth, and F. Grosse Fidelity of reverse transcriptase of the simian immunodeficiency virus from African green monkey Nucleic Acids Res. 19 1991 533 537
30. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 2003 21 31
31. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9 2003 1398 1403
32. A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway J. Biol. Chem. 279 2004 7792 7798
33. E.N. Newman, R.K. Holmes, H.M. Craig, K.C. Klein, J.R. Lingappa, M.H. Malim, and A.M. Sheehy Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity Curr. Biol. 15 2005 166 170
34. T.W. Nilsen The spliceosome: the most complex macromolecular machine in the cell? BioEssays 25 2003 1147 1149
35. I.W. Park, R. Steen, and Y. Li Characterization of multiple mRNA species of simian immunodeficiency virus from macaques in a CD4+ lymphoid cell line J. Virol. 65 1991 2987 2992
36. I.W. Park, K. Myrick, and J. Sodroski Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus J. Acquired Immune Defic. Syndr. 7 1994 1228 1236
37. D.F. Purcell, and M.A. Martin Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity J. Virol. 67 1993 6365 6378
38. T.A. Reinhart, M.J. Rogan, and A.T. Haase RNA splice site utilization by simian immunodeficiency viruses derived from sooty mangabey monkeys Virology 224 1996 338 344
39. W.E. Robinson Jr., D.C. Montefiori, D.H. Gillespie, and W.M. Mitchell Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release J. Acquired Immune Defic. Syndr. 2 1989 33 42
40. D. Ropers, L. Ayadi, R. Gattoni, S. Jacquenet, L. Damier, C. Branlant, and J. Stevenin Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA J. Biol. Chem. 279 2004 29963 29973
41. K.M. Rose, M. Marin, S.L. Kozak, and D. Kabat Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus J. Biol. Chem. 279 2004 41744 41749
42. H. Sakai, R. Shibata, J. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles J. Virol. 67 1993 1663 1666
43. A. Schafer, H.P. Bogerd, and B.R. Cullen Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor Virology 328 2004 163 168
44. B. Schrofelbauer, D. Chen, and N.R. Landau A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) Proc. Natl. Acad. Sci. U. S. A. 101 2004 3927 3932
45. S. Schwartz, K.F. Barbar, and G.N. Pavlakis Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing Virology 183 1991 677 686
46. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 2002 646 650
47. A.M. Sheehy, N.C. Gaddis, and M.H. Malim The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat. Med. 9 2003 1404 1407
48. K. Shindo, A. Takaori-Kondo, M. Kobayashi, A. Abudu, K. Fukunaga, and T. Uchiyama The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity J. Biol. Chem. 278 2003 44412 44416
49. P. Sova, and D.J. Volsky Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1 J. Virol. 67 1993 6322 6326
50. K. Stopak, C. de Noronha, W. Yonemoto, and W.C. Greene HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol. Cell 12 2003 591 601
51. R. Suspene, P. Sommer, M. Henry, S. Ferris, D. Guetard, S. Pochet, A. Chester, N. Navaratnam, S. Wain-Hobson, and J.P. Vartanian APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase Nucleic Acids Res. 32 2004 2421 2429
52. H. Takeuchi, S. Kao, E. Miyagi, M.A. Khan, A. Buckler-White, R. Plishka, and K. Strebel Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G J. Biol. Chem. 280 2005 375 382
53. P. Turelli, B. Mangeat, S. Jost, S. Vianin, and D. Trono Inhibition of hepatitis B virus replication by APOBEC3G Science 303 2004 1829
54. R.E. Unger, M.W. Stout, and P.A. Luciw Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA Virology 182 1991 177 185
55. J.G. Victoria, D.J. Lee, B.R. McDougall, and W.E. Robinson Jr. Replication kinetics for divergent type 1 human immunodeficiency viruses using quantitative SYBR green I real-time polymerase chain reaction AIDS Res. Hum. Retroviruses 19 2003 865 874
56. G.A. Viglianti, P.L. Sharma, and J.L. Mullins Simian immunodeficiency virus displays complex patterns of RNA splicing J. Virol. 64 1990 4207 4216
57. U. von Schwedler, J. Song, C. Aiken, and D. Trono Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells J. Virol. 67 1993 4945 4955
58. H.L. Wiegand, B.P. Doehle, H.P. Bogerd, and B.R. Cullen A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins EMBO J. 23 2004 2451 2458
59. S.K. Wong, and D.W. Lazinski Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1 Proc. Natl. Acad. Sci. U. S. A. 99 2002 15118 15123
60. H. Xu, E.S. Svarovskaia, R. Barr, Y. Zhang, M.A. Khan, K. Strebel, and V.K. Pathak A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion Proc. Natl. Acad. Sci. U. S. A. 101 2004 5652 5657
61. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 2003 1056 1060
62. Q. Yu, D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N.R. Landau APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication J. Biol. Chem. 279 2004 53379 53386
63. Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney, S. Palmer, D. Richman, J.M. Coffin, and N.R. Landau Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat. Struct. Mol. Biol. 11 2004 435 442
64. V. Zennou, D. Perez-Caballero, H. Gottlinger, and P.D. Bieniasz APOBEC3G incorporation into human immunodeficiency virus type 1 particles J. Virol. 78 2004 12058 12061
65. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98
66. Y.H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B.M. Peterlin Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J. Virol. 78 2004 6073 6076
67. J.X. Zou, and P.A. Luciw The requirement for Vif of SIVmac is cell-type dependent J. Gen. Virol. 77 1996 427 434